Fgfr1c antibody combinations
OwnerAndrew Beaton, Sean Matthew Cleveland +2inventors
InventorsAndrew Beaton, Sean Matthew Cleveland, Gerald Wayne Gough, Mark Andrew Paulik
Life of this patent
Estimating the term…
Abstract
The invention relates to combinations of FGFR1c antagonists with agonist peptides and provide dual targeting proteins which bind to FEFR1c comprising an antigen binding protein which is capable of binding to FGFR1c and which is linked to one or more agonist peptides, methods of making such constructs and uses thereof, particularly in treating obesity.
Claims15
1-33. (canceled)
A composition comprising an FGFR1c antagonist and an agonist peptide.
A dual targeting protein comprising an antigen binding protein which is capable of binding to FGFR1c, and which is linked to one or more agonist peptides.
Dependencies are inferred from the claim text.